drugset / Trial / NCT07843420
Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research is to investigate the efficacy of nemolizumab in the treatment of adults with moderate to severe chronic hepatic pruritus.
Timeline
- Start
- 2026-11
- Primary completion
- 2028-11
- Completion
- 2028-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nemolizumab | Monoclonal antibody | 30 mg | Subcutaneous |